BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23523586)

  • 1. Effects of low dose treatment of tributyltin on the regulation of estrogen receptor functions in MCF-7 cells.
    Sharan S; Nikhil K; Roy P
    Toxicol Appl Pharmacol; 2013 Jun; 269(2):176-86. PubMed ID: 23523586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of thyroid hormone functions by low dose exposure of tributyltin: an in vitro and in vivo approach.
    Sharan S; Nikhil K; Roy P
    Gen Comp Endocrinol; 2014 Sep; 206():155-65. PubMed ID: 25101840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organotin compounds cause structure-dependent induction of progesterone in human choriocarcinoma Jar cells.
    Hiromori Y; Yui H; Nishikawa J; Nagase H; Nakanishi T
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):190-8. PubMed ID: 25465476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the environmental contaminants DEHP and TCDD on estradiol synthesis and aryl hydrocarbon receptor and peroxisome proliferator-activated receptor signalling in the human granulosa cell line KGN.
    Ernst J; Jann JC; Biemann R; Koch HM; Fischer B
    Mol Hum Reprod; 2014 Sep; 20(9):919-28. PubMed ID: 24950685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The environmental chemical tributyltin chloride (TBT) shows both estrogenic and adipogenic activities in mice which might depend on the exposure dose.
    Penza M; Jeremic M; Marrazzo E; Maggi A; Ciana P; Rando G; Grigolato PG; Di Lorenzo D
    Toxicol Appl Pharmacol; 2011 Aug; 255(1):65-75. PubMed ID: 21683088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organotin compounds act as inhibitor of transcriptional activation with human estrogen receptor.
    Cho EM; Lee HS; Moon JS; Kim IS; Sim S; Ohta A
    J Microbiol Biotechnol; 2012 Mar; 22(3):378-84. PubMed ID: 22450794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AroER tri-screen is a biologically relevant assay for endocrine disrupting chemicals modulating the activity of aromatase and/or the estrogen receptor.
    Chen S; Zhou D; Hsin LY; Kanaya N; Wong C; Yip R; Sakamuru S; Xia M; Yuan YC; Witt K; Teng C
    Toxicol Sci; 2014 May; 139(1):198-209. PubMed ID: 24496634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of zebrafish estrogen receptor subtypes by chemicals by using stable reporter gene assay developed in a zebrafish liver cell line.
    Cosnefroy A; Brion F; Maillot-Maréchal E; Porcher JM; Pakdel F; Balaguer P; Aït-Aïssa S
    Toxicol Sci; 2012 Feb; 125(2):439-49. PubMed ID: 22045033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation.
    Masuda H; Otsuka F; Matsumoto Y; Takano M; Miyoshi T; Inagaki K; Shien T; Taira N; Makino H; Doihara H
    Mol Cell Endocrinol; 2011 Aug; 343(1-2):7-17. PubMed ID: 21664418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptors, estrogenic responses and biotransformation system in the liver of salmon exposed to tributyltin and second messenger activator.
    Pavlikova N; Kortner TM; Arukwe A
    Aquat Toxicol; 2010 Aug; 99(2):176-85. PubMed ID: 20466441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obacunone exhibits anti-proliferative and anti-aromatase activity in vitro by inhibiting the p38 MAPK signaling pathway in MCF-7 human breast adenocarcinoma cells.
    Kim J; Jayaprakasha GK; Patil BS
    Biochimie; 2014 Oct; 105():36-44. PubMed ID: 24927687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of tributyltin chloride and triphenyltin chloride on cell proliferation, proapoptotic p53, Bax, and antiapoptotic Bcl-2 protein levels in human breast cancer MCF-7 cell line.
    Fickova M; Macho L; Brtko J
    Toxicol In Vitro; 2015 Jun; 29(4):727-31. PubMed ID: 25743928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a stable dual cell-line GFP expression system to study estrogenic endocrine disruptors.
    Xu H; Kraus WL; Shuler ML
    Biotechnol Bioeng; 2008 Dec; 101(6):1276-87. PubMed ID: 18980187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens.
    Kanaya N; Nguyen DM; Lu H; Wang YZ; Hsin LY; Petreas M; Nelson D; Guo W; Reynolds P; Synold T; Chen S
    Breast Cancer Res Treat; 2015 Jun; 151(2):335-45. PubMed ID: 25962693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-tert-Octylphenol stimulates the expression of cathepsins in human breast cancer cells and xenografted breast tumors of a mouse model via an estrogen receptor-mediated signaling pathway.
    Lee HR; Choi KC
    Toxicology; 2013 Feb; 304():13-20. PubMed ID: 23219593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways.
    Gao QG; Chen WF; Xie JX; Wong MS
    J Neurochem; 2009 Jun; 109(5):1338-47. PubMed ID: 19476546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts.
    Bodine PV; Harris HA; Komm BS
    Endocrinology; 1999 Jun; 140(6):2439-51. PubMed ID: 10342828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.